Evaluation of Plasma Angiotensin II and Angiotensin II Receptor Levels in Patients With Sepsis and Septic Shock: a Prospective Observational Study.
NCT04716842 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2021-01-20
Summary
Evaluation of plasma angiotensin II and angiotensin II receptor levels in patients with sepsis and septic shock: a prospective observational study.
Conditions
- Sepsis
- Septic Shock
Sponsors & Collaborators
-
Inonu University
lead OTHER
Principal Investigators
-
Ayse Belin B OZER · Inonu University Faculty of Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2021-04-30
- Completion
- 2021-04-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Sepsis Early EvaluatioN Through Rapid Ultrasound and veNous Gas Analysis
NCT05787184 ·Status: UNKNOWN
-
Effects of Chronic Antihypertensive Therapy on Clinical Outcomes in Septic Shock
NCT02876341 ·Status: COMPLETED
-
Observational Study About the Use of Perfusion Index to Use Vasopressor in Sepsis
NCT06860438 ·Status: RECRUITING
-
Evaluation of Serum Procalcitonin in Critically Ill Patients With Suspected Sepsis
NCT03506152 ·Status: COMPLETED
-
Sepse: Critical Analysis of New Sepse Definitions and Retrospective Evaluation of Sepse Protocol at a Tertiary Hospital in Brazil
NCT03217981 ·Status: UNKNOWN
-
Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock
NCT05358912 ·Status: COMPLETED ·Phase: PHASE4
-
Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients
NCT06904001 ·Status: ENROLLING_BY_INVITATION
-
IL-40 and IL-41 Levels in Sepsis, Septic Shock, and Healthy Individuals
NCT06963541 ·Status: NOT_YET_RECRUITING
-
Assessment of Fluid Responsiveness in Septic Shock Patients, Can End-tidal co2 Measurement Help?
NCT05557461 ·Status: UNKNOWN
-
Vasopressin Use in Septic Shock From Türkiye
NCT06953297 ·Status: COMPLETED
-
Evaluating the Effect of Chronic Antihypertensive Therapy on Vasopressor Dosing in Septic Shock
NCT02884011 ·Status: COMPLETED
-
Assessment of Two Levels of Arterial Pressure on Survival in Patients With Septic Shock
NCT01149278 ·Status: COMPLETED ·Phase: NA
-
The Effect of Vasopressor Therapy on Renal Perfusion in Septic Shock
NCT06234592 ·Status: RECRUITING ·Phase: NA
-
Carotid Ultrasounds Measurements in Septic Shock
NCT05444621 ·Status: UNKNOWN
-
Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis
NCT04280497 ·Status: RECRUITING ·Phase: NA
-
Prognostic Power of the VEXUS Score in Septic Shock: Effectiveness in Mortality Prediction
NCT07124741 ·Status: NOT_YET_RECRUITING
-
Validation of Molecular and Protein Biomarkers in Sepsis
NCT04289506 ·Status: UNKNOWN
-
Sensitivity and Specificity of Leucocytes Profiling Versus Platelet Indices in Prediction of Clinical Outcome for Candidates With Sepsis. A Bi-centric Observational Clinical Trial
NCT06612307 ·Status: COMPLETED
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328 ·Status: UNKNOWN
-
NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock
NCT02454348 ·Status: WITHDRAWN ·Phase: PHASE4
-
Comparison of Radial and Femoral Artery Site Invasive Blood Pressure Measurement in Septic Shock Patients
NCT03475667 ·Status: COMPLETED
-
Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock
NCT00279214 ·Status: COMPLETED ·Phase: PHASE4
-
Hydrocortisone for Prevention of Septic Shock
NCT00670254 ·Status: COMPLETED ·Phase: PHASE3
-
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT05681442 ·Status: RECRUITING ·Phase: PHASE4